Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Professional Survey Report 2019
SKU ID : QYR-14867740 | Publishing Date : 06-Nov-2019 | No. of pages : 109
The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b volume and value at global level, regional level and company level. From a global perspective, this report represents overall Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BioInvent International AB
MacroGenics, Inc.
Shire Plc
Xencor, Inc.
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
XmAb-7195
BI-1206
MGD-010
SM-201
Others
Segment by Application
Hospital
Clinic
Others
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region